MENU
CYCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cyclerion Therapeutics (CYCN) Ownership - Who owns Cyclerion Therapeutics?

Profile

Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.45M
P/E Ratio
N/A
Total Cash
870K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
0.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CYCN
Capitalization
4.45M
P/E Ratio
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
870K
Total Cash/Share
0.35
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
9.92M
P/B Ratio
0.51
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
4.17
Current Revenue Per Employee
2250.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
3.18M
Shares Outstanding - Current
2.52M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
-47.164
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com